Autologous Whole-blood Injections in Chronic Spontaneous Urticaria: Assessment of Efficacy Biomarkers

  • Nikolaos Aggelis Kitsioulis Mail Department of Allergy, 2nd Pediatric Clinic, National and Kapodistrian University of Athens, Athens, Greece AND Department of Dermatology, University General Hospital Larissa, University of Thessaly, Larissa, Greece
  • Efterpi Zafiriou ORCID Department of Dermatology, University General Hospital Larissa, University of Thessaly, Larissa, Greece
  • Paraskevi Xepapadaki ORCID Department of Allergy, 2nd Pediatric Clinic, National and Kapodistrian University of Athens, Athens, Greece
  • Styliani Taka ORCID Department of Allergy, 2nd Pediatric Clinic, National and Kapodistrian University of Athens, Athens, Greece
  • Nikolaos G. Papadopoulos ORCID Department of Allergy, 2nd Pediatric Clinic, National and Kapodistrian University of Athens, Athens, Greece
  • Angeliki-Viktoria Roussaki-Schulze ORCID Department of Dermatology, University General Hospital Larissa, University of Thessaly, Larissa, Greece
Keywords:
No Keyword, Keywords

Abstract

Abstract Abstract Abstract Abstract

References

1. You HS, Cho HH, Kim WJ, Mun JH, Song M, Kim HS, et al. Autologous Whole Blood Injection for the Treatment of Antihistamine-Resistant Chronic Spontaneous Urticaria. Ann Dermatol. 2015;27(6):784-6.
2. Dos Santos JC, Azor MH, Nojima VY, Lourenco FD, Prearo E, Maruta CW, et al. Increased circulating pro-inflammatory cytokines and imbalanced regulatory T-cell cytokines production in chronic idiopathic urticaria. Int Immunopharmacol. 2008;8(10):1433-40.
3. Kasperska-Zajac A, Grzanka A, Damasiewicz-Bodzek A. IL-6 Transsignaling in Patients with Chronic Spontaneous Urticaria. PloS one. 2015;10(12):e0145751.
4. Degirmenci PB, Kirmaz C, Vatansever S, Onur E, Nal E, Erdin S, et al. Analysis of the association of chronic spontaneous urticaria with interlekin-4, -10, transforming growth factor-beta1, interferon-gamma, interleukin-17A and -23 by autologous serum skin test. Postepy Dermatol Alergol. 2017;34(1):70-6.
5. Lin W, Zhou Q, Liu C, Ying M, Xu S. Increased plasma IL-17, IL-31, and IL-33 levels in chronic spontaneous urticaria. Sci Rep. 2017;7(1):17797.
6. Chen T, Fu LX, Sun QM, Zhou PM, Guo ZP. Decreased interleukin-35 serum levels in patients with chronic spontaneous urticaria. Ann Allergy Asthma Immunol. 2018;121(4):503-4.
7. Kitsioulis NA, Xepapadaki P, Roussaki-Schulze AV, Papadopoulos N, Zafiriou E. Effectiveness of Autologous Whole-Blood Injections in Patients with Refractory Chronic Spontaneous Urticaria. Int Arch Allergy Immunol. 2017;172(3):161-6.
8. Futata E, Azor M, Dos Santos J, Maruta C, Sotto M, Guedes F, et al. Impaired IFN-alpha secretion by plasmacytoid dendritic cells induced by TLR9 activation in chronic idiopathic urticaria. The Br J Dermatol. 2011;164(6):1271-9.
9. Chong WP, van Panhuys N, Chen J, Silver PB, Jittayasothorn Y, Mattapallil MJ, et al. NK-DC crosstalk controls the autopathogenic Th17 response through an innate IFN-gamma-IL-27 axis. J Eex Med. 2015;212(10):1739-52.
Published
2020-04-16
How to Cite
1.
Kitsioulis N, Zafiriou E, Xepapadaki P, Taka S, Papadopoulos N, Roussaki-Schulze A-V. Autologous Whole-blood Injections in Chronic Spontaneous Urticaria: Assessment of Efficacy Biomarkers. Iran J Allergy Asthma Immunol. 19(2):206-208.
Section
Letter to the Editor